Most cited papers from HRA Pharma (France)

HRA Pharma (France)

What are the most cited papers from HRA Pharma (France)?

The most cited paper from HRA Pharma (France) is "Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis" (Anna F. Glasier, Sharon Tracey Cameron, Paul M Fine et al., 2010), with 530 citations. Next come "Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study" (173) and "Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture" (171).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 82 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis Anna F. Glasier, Sharon Tracey Cameron, Paul M Fine et al. · The Lancet	30 Jan 2010	530
2	Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study Ilse G.C. Hermsen, Martin Faßnacht, Massimo Terzolo et al. · The Journal of Clinical Endocrinology & Metabolism	7 Apr 2011	173
3	Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture Vivian Brache, Leila Cochón, Cristián Jesam et al. · Human Reproduction	15 Jul 2010	171
4	Ulipristal Acetate Taken 48–120 Hours After Intercourse for Emergency Contraception Paul M Fine, Henri Mathé, Savita Y. Ginde et al. · Obstetrics and Gynecology	19 Jan 2010	161
5	A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference Paulus F. Kirchhof et al. · EP Europace Open access	18 Oct 2015	142
6	Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference Paulus F. Kirchhof et al. · EP Europace Open access	27 Aug 2013	141
7	Intrauterine device insertion in the postpartum period: A systematic review Sarita Sonalkar, Nathalie Kapp · The European Journal of Contraception & Reproductive Health Care Review	14 Nov 2014	104
8	Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion Miguel Debono, Robert F. Harrison, Rita Chadarévian et al. · The Journal of Clinical Endocrinology & Metabolism Open access	30 Jun 2017	99
9	Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells S. Hescot, Abdelhamid Slama, Anne Lombès et al. · Endocrine Related Cancer Open access	5 Apr 2013	98
10	Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma Thomas M. A. Kerkhofs, Éric Baudin, Massimo Terzolo et al. · The Journal of Clinical Endocrinology & Metabolism Open access	20 Sep 2013	93
11	Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception Nathalie Kapp, Jean Louis Abitbol, Henri Mathé et al. · Contraception	8 Nov 2014	91
12	Bisphosphonates and bone quality Michael Pazianas, Stefan van der Geest, Paul D. Miller · BoneKEy Reports Open access	7 May 2014	86
13	A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception Vivian Brache, Leila Cochón, Ingrid J. M. Duijkers et al. · Human Reproduction Open access	23 Sep 2015	76
14	Ulipristal acetate for emergency contraception: postmarketing experience after use by more than 1 million women Delphine Lévy, Martine Johanna Jager, Nathalie Kapp et al. · Contraception	13 Jan 2014	75
15	Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France Jacques Young et al. · European Journal of Endocrinology 136 authors	23 Feb 2018	70
16	Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal Erin Gainer, Jennifer Blum, Else-Lydia Toverud et al. · Contraception	Aug 2003	69
17	Pharmacologic properties of CDB(VA)-2914 Erin Gainer, André Ulmann · Steroids	12 Sep 2003	62
18	Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study Miguel Debono, Rita Chadarévian, Richard Eastell et al. · PLoS ONE Open access	5 Apr 2013	60
19	Plasmodium falciparum STEVOR phosphorylation regulates host erythrocyte deformability enabling malaria parasite transmission Bernina Naissant, Florian Dupuy, Yoann Duffier et al. · Blood	2 May 2016	57
20	Complexification of In Vitro Models of Intestinal Barriers, A True Challenge for a More Accurate Alternative Approach Michelle J. Haddad, Wendy Sztupecki, Carine Delayre‐Orthez et al. · International Journal of Molecular Sciences Open access	10 Feb 2023	50
21	Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors Isabelle Petit-Topin, Michel Fay, Matthieu Resche‐Rigon et al. · The Journal of Steroid Biochemistry and Molecular Biology	6 Sep 2014	50
22	Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception Erin Gainer, R. Massai, S Pena y Lillo et al. · Human Reproduction	2 Mar 2007	45
23	Menstrual bleeding patterns following levonorgestrel emergency contraception Erin Gainer, Bruno Kenfack, Emile Télesphore Mboudou et al. · Contraception Open access	3 May 2006	44
24	Mechanical clearance of red blood cells by the human spleen: Potential therapeutic applications of a biomimetic RBC filtration method Julien Duez, John P. Holleran, Papa Alioune Ndour et al. · Transfusion Clinique et Biologique	2 Jul 2015	43
25	The development of mifepristone: a pharmaceutical drama in three acts. A Ulmann · PubMed	2000	40
26	Levonorgestrel-only emergency contraception: real-world tolerance and efficacy Erin Gainer, Christian Méry, André Ulmann · Contraception	Jul 2001	37
27	The pharmacokinetics of 750 μg levonorgestrel following administration of one single dose or two doses at 12- or 24-h interval Dominique Tremblay, Erin Gainer, André Ulmann · Contraception	Dec 2001	29
28	A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate Cristián Jesam, Leila Cochón, A.M. Salvatierra et al. · Contraception	4 Jan 2016	28
29	Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta‐regression analysis to develop an enrichment strategy Bruno Scherrer et al. · Alcoholism Clinical and Experimental Research Open access	21 Aug 2021	27
30	Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects Giovanni Addolorato, Otto‐Michael Lesch, Icro Maremmani et al. · Expert Opinion on Drug Safety	26 Dec 2019	27
31	Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression Nathalie Esber, Florian Le Billan, Matthieu Resche‐Rigon et al. · PLoS ONE Open access	16 Oct 2015	25
32	Is it worth paying more for emergency hormonal contraception? The cost-effectiveness of ulipristal acetate versus levonorgestrel 1.5 mg Christine Thomas, Ramona Schmid, Sharon Tracey Cameron · Journal of Family Planning and Reproductive Health Care Open access	Oct 2010	24
33	Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model Nathalie Esber, Clément Cherbonnier, Matthieu Resche‐Rigon et al. · Hormones and Cancer Open access	3 Mar 2016	23
34	Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study Julien Guiraud, Giovanni Addolorato, Henri‐Jean Aubin et al. · European Neuropsychopharmacology Open access	5 Jul 2021	21
35	ProNGF promotes brain metastasis through TrkA/EphA2 induced Src activation in triple negative breast cancer cells Julien Cicero et al. · Experimental Hematology and Oncology Open access	10 Dec 2023	20
36	Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery Elisa L. J. Moya, Elodie Vandenhaute, Eleonora Rizzi et al. · Pharmaceutics Open access	16 Jun 2021	20
37	Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients Dominique M. Maiter, Marie Bex, Laurent Vroonen et al. · Annales d Endocrinologie	9 Apr 2016	20
38	Unmet needs in Cushing’s syndrome: the patients’ perspective Elena Valassi, Iacopo Chiodini, Richard Abraham Feelders et al. · Endocrine Connections Open access	14 Jun 2022	19
39	A review of the effectiveness of a progestogen-only pill containing norgestrel 75 µg/day Anna F. Glasier, Stephanie Sober, Robin Gasloli et al. · Contraception Open access	6 Sep 2021	19
40	Does ulipristal acetate emergency contraception (ella®) interfere with implantation? Raymond Li, Matthieu Resche‐Rigon, Indrani C. Bagchi et al. · Contraception	24 Jul 2019	18
41	Surfing on the morning after: analysis of an emergency contraception website Erin Gainer, Christian Sollet, Marion Ulmann et al. · Contraception	Mar 2003	18
42	Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells Elisa L. J. Moya, Sonia M. Lombardo, Elodie Vandenhaute et al. · International Journal of Pharmaceutics Open access	3 May 2022	17
43	Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial Julien Guiraud et al. · Journal of Psychopharmacology Open access	7 Jul 2022	16
44	Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity Anna F. Glasier, Alison B. Edelman, Mitchell David Creinin et al. · Contraception Open access	26 Mar 2022	16
45	Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S. Hélène Guillard, Irene Laurora, Stephanie Sober et al. · Contraception Open access	17 Oct 2022	15
46	The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France Ramona Schmid · PLoS ONE Open access	30 Sep 2015	15
47	The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study Anna F. Glasier, Alison B. Edelman, Mitchell David Creinin et al. · Contraception Open access	18 Sep 2022	14
48	The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg Camille Banh, Tanja Rautenberg, Ingrid J. M. Duijkers et al. · Contraception	29 May 2020	14
49	FibriDerm: Interpenetrated Fibrin Scaffolds for the Construction of Human Skin Equivalents for Full Thickness Burns Olfat Gsib, Marie Deneufchatel, Mathieu Goczkowski et al. · IRBM	14 Nov 2017	13
50	Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception Leo Han, Mitchell David Creinin, Agnes Hemon et al. · Contraception Open access	31 Mar 2022	11

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.